AGILE THERAPEUTICS INC (AGRX)
US00847L3087 - Common Stock
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 2.90M | 5.25M | 19.14M | 14.46M | 34.48M | |||
| Marketable Securities | N/A | N/A | 0.00 | 40.01M | N/A | |||
| Receivables | 3.50M | 3.38M | 1.53M | 870.00K | N/A | |||
| Inventories | 2.40M | 1.33M | 970.00K | N/A | N/A | |||
| Other Current Assets | 1.30M | 1.41M | 2.29M | 1.45M | 840.00K | |||
| Total Current Assets | 10.10M | 11.36M | 23.93M | 56.79M | 35.32M | |||
| Non-Current Assets | ||||||||
| PPE Net | 600.00K | 870.00K | 13.40M | 14.38M | 14.22M | |||
| Other Non-Current Assets | 200.00K | 2.01M | 2.01M | 1.90M | N/A | |||
| Total Non-Current Assets | 800.00K | 2.88M | 15.40M | 16.27M | 14.22M | |||
| TOTAL ASSETS | 10.90M | 14.24M | 39.33M | 73.06M | 49.54M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 2.00M | 1.43M | 16.83M | N/A | N/A | |||
| Accrued Expenses | 8.70M | 4.23M | 3.74M | 3.49M | 1.98M | |||
| Accounts Payable | 6.90M | 7.73M | 8.71M | 3.87M | 1.82M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 17.50M | 13.39M | 29.28M | 7.35M | 3.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 16.38M | 0.00 | |||
| Other Non-Current Liabilities | 5.80M | 6.40M | 780.00K | N/A | N/A | |||
| Total Non-Current Liabilities | 5.80M | 6.40M | 780.00K | 16.38M | 0.00 | |||
| TOTAL LIABILITIES | 23.30M | 19.79M | 30.06M | 23.73M | 3.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -418.70M | -408.70M | -387.12M | -312.22M | -260.37M | |||
| Additional Paid In Capital | 406.30M | 403.15M | 396.38M | 361.54M | 306.11M | |||
| Common Shares | N/A | 0.00 | 10.00K | 10.00K | 10.00K | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | 0.00 | N/A | |||
| Shares Outstanding | 2.30M | 860.00K | 60.00K | 40.00K | 30.00K | |||
| Tangible Book Value per Share | -5.39 | -6.45 | 154.50 | 1.23K | 1.52K | |||
| Total Shareholders' Equity | -12.40M | -5.55M | 9.27M | 49.33M | 45.75M | |||
| TOTAL LIABILITIES AND EQUITY | 10.90M | 14.24M | 39.33M | 73.06M | 49.54M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.33 | N/A | |||
| Current Ratio | 0.58 | 0.85 | 0.82 | 7.73 | 9.29 | |||
| Return On Assets (ROA) | 75.60% | -178.44% | -180.70% | -70.97% | -37.57% | |||
| Return On Equity (ROE) | N/A | N/A | -766.67% | -105.11% | -40.68% | |||
All data in USD